Final Results, Notice of AGM, Updated NAV
22 Mars 2024 - 8:00AM
UK Regulatory
Final Results, Notice of AGM, Updated NAV
Annual Report for the year ended 31
December 2023, Notice of AGM and updated unaudited NAV
Seneca Growth Capital VCT Plc (the
"Company")
22 March 2024
The Company is pleased to report that it has
published its annual report and financial statements for the year
ended 31 December 2023.
The associated PDF document can be downloaded by
clicking the link below at the bottom of the RNS announcement.
The annual report and financial statements for the
year ended 31 December 2023 may also be downloaded from the
Company’s website at
https://senecavct.co.uk/reports-documents/.
A copy of the annual report and financial
statements will also be submitted shortly to the National Storage
Mechanism ("NSM") and will be available for inspection at the NSM,
which is situated at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The annual report contains a notice of the Annual
General Meeting (“AGM”). The Company’s AGM will be held at 11:00
a.m. on Wednesday, 15 May 2024 at the Company’s registered address
9 The Parks, Haydock, WA12 0JQ.
For any shareholders wishing to attend the AGM this
year in person, we request that you please inform us in advance by
e-mailing enquiries@senecavct.co.uk so that we may register
your attendance with the facilities manager in order to issue you
with the appropriate attendance pass.
For those unable to attend, we will be hosting our
bi-annual shareholder update presentation with a question and
answer (Q&A) session included, starting at 11:00 a.m. on 7 May
2024. Shareholders should note that only the formal business set
out in the notice of AGM will be considered at the AGM and we
encourage shareholders to attend the presentation and ask questions
prior to the AGM. Further details about the shareholder update
presentation can be found on the Company’s website at
https://senecavct.co.uk/shareholder-update/may-2024/.
As a result of a reduction in share prices of some
of the B share pool’s AIM quoted investments since the year end,
the B share pool’s updated unaudited NAV is 63.8p per B share as at
20 March 2024.
The share prices of both Ordinary share pool AIM
quoted investments Arecor and Scancell also decreased since the
year end, which has resulted in an updated Ordinary share pool
unaudited NAV of 16.9p per Ordinary share as at 20 March 2024.
This announcement contains inside information as
stipulated under the UK version of the Market Abuse Regulation No
596/2014 which is part of English Law by virtue of the European
(Withdrawal) Act 2018, as amended. Upon the publication of this
announcement via a Regulatory Information Service, this information
is now considered to be in the public domain.
Seneca-VCT-Annual-Report-March-2024-Final
For further information, please
contact:
John Hustler, Seneca Growth Capital VCT Plc
at john.hustler@btconnect.com
Richard Manley, Seneca Growth Capital VCT Plc
at Richard.Manley@senecapartners.co.uk
- Seneca-VCT-Annual-Report-March-2024-Final
Bioscience Vct (LSE:BVP)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Bioscience Vct (LSE:BVP)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024